Physician profile
Gregory Bartos
NPI 1427513308
$7,326.49
in general payments reported to CMS, 2019-2025
34 companies · $2,455 in 2025
The $2,455 reported for 2025 was more than what 81% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $180 · 2021: $323 · 2022: $1,062 · 2023: $1,181 · 2024: $2,126 · 2025: $2,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,672 · Education: $89.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,672.12 |
| Education | $89.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,647.75 | 2021-2025 | Skyrizi, Rinvoq |
| Organogenesis INC. | $1,618.31 | 2023-2025 | Via Matrix, Puraply, Simplimax |
| Genzyme Corporation | $510.62 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $307.17 | 2024-2025 | Acthar |
| Janssen Biotech, INC. | $306.32 | 2022-2025 | Tremfya, Simponi Aria, Simponi |
| Pfizer INC. | $302.45 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $299.59 | 2020-2025 | Dupixent, Libtayo |
| Ucb, INC. | $283.26 | 2022-2025 | Bimzelx, Cimzia |
| Incyte Corporation | $235.98 | 2022-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $230.40 | 2021-2025 | Absorica Ld, Winlevi |
| Biofrontera INC. | $189.12 | 2021-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Galderma Laboratories, L.P. | $148.83 | 2020-2025 | Nemluvio |
| Lilly USA, LLC | $127.84 | 2020-2025 | Olumiant, Ebglyss |
| Janssen Scientific Affairs, LLC | $124.58 | 2022 | |
| Mayne Pharma Commercial LLC | $117.29 | 2023-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $102.05 | 2024-2025 | Adbry, Anzupgo |
| Sanofi-Aventis U.S. LLC | $89.95 | 2024 | |
| Organon LLC | $83.38 | 2025 | |
| Botanix Sb INC | $73.36 | 2025 | Sofdra |
| Novartis Pharmaceuticals Corporation | $70.27 | 2022-2023 | |
| Arcutis Biotherapeutics, INC. | $66.29 | 2025 | Zoryve |
| Dermavant Sciences, INC. | $53.34 | 2023 | Vtama |
| Amgen INC. | $51.45 | 2022-2023 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $46.81 | 2021-2023 | Jublia, Arazlo |
| Journey Medical Corporation | $34.81 | 2023-2025 | |
| Vyne Pharmaceuticals INC. | $30.18 | 2021 | |
| Paratek Pharmaceuticals, INC. | $24.55 | 2021 | |
| Cipher Pharmaceuticals US LLC | $24.12 | 2025 | Natroba, Spinosad |
| Lnhc, INC | $23.90 | 2025 | Zelsuvmi |
| Smith+Nephew, INC. | $22.15 | 2023 | Collagenase Santyl |
| Kyowa Kirin, INC. | $21.93 | 2021 | |
| Novo Nordisk INC | $20.67 | 2021 | |
| Almirall LLC | $20.31 | 2025 | Klisyri |
| Helsinn Therapeutics (U.S.), INC. | $17.46 | 2024 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bartos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.